Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT01564056

Active, not recruiting

Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment (ASTER 70s)

Breast Cancer
NCT04132960

Completed

Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis (DAISY)

Breast Tumors
NCT04688697

Active, not recruiting

Prepectoral and Subpectoral Implant-based Breast Reconstruction

Breast Carcinoma | Breast Reconstruction
NCT03422003

Active, not recruiting

Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma

Breast Cancer
NCT05976620

Completed

Clinical Study of 18F-FAPI-RGD in Breast Tumors

Breast Tumors
NCT00639171

Completed

Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or Malignant

Breast Tumors
NCT04767464

Completed

Feasibility of Providing a Purpose Renewal Intervention for Cancer Survivors Via Virtual Groups (CC-V)

Breast Cancer | Breast Neoplasm
NCT05558917

Enrolling by invitation

Comparison Between PECS BLOCK 2 vs ESP BLOCK in Ocnologic Breast Surgery (ESPECS)

Breast Cancer | Breast Neoplasms | Breast Carcinoma
NCT04828044

Withdrawn

Microwave Ablation of Breast Tumors

Breast Cancer
NCT01372631

Completed

A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins

Breast Cancer
NCT02794558

Completed

Safety and Effectiveness of MR Guided Focused Ultrasound Surgery in the Treatment of Early Breast Carcinomas

Breast Cancer
NCT00977275

Completed

Treatment of T1N0 Invasive Breast Carcinoma by Local Excision Implant

Breast Cancer
NCT00968409

Completed

Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using Fluoro Furanyl Norprogesterone (FFNP) (FFNP)

Breast Cancer
NCT01993576

Completed

ICG Distribution Using NIF Imaging After IV Injection of ICG in Benign and Malignant Breast Cancer Tissue. (EC2075)

Breast Cancer.
NCT01903174

Completed

Study of AeroForm Tissue Expander for Breast Reconstruction (ASPIRE)

Breast Cancer | Breast Reconstruction
NCT00941408

Unknown

Biomarker Study of Breast Tumors

Breast Tumors
NCT00005908

Completed

Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer

Breast Cancer | Breast Neoplasm
NCT00206414

Terminated

Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer

BREAST CANCER
NCT00001837

Completed

Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients

Breast Cancer | Breast Neoplasm
NCT07106632

Not yet recruiting

Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests (OPTIMA-YOUNG)

Early Breast Cancer | Premenopausal Breast Cancer | HR+/HER2- Breast Cancer
NCT05953168

Not yet recruiting

T-DXd in the First-Line Treatment of Locally Advanced or Metastatic TNBC-LAR HER2-low Patients

Triple-Negative Breast Cancer
NCT05541367

Recruiting

Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer

Breast Cancer | TNBC - Triple-Negative Breast Cancer | Estrogen-receptor-negative Breast Cancer
NCT04138719

Recruiting

Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer

Breast Cancer | Triple-negative Breast Cancer | Nab-paclitaxel
NCT02448771

Completed

A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer

Breast Cancer Stage IV | Unresectable Locally Advanced Invasive Breast Cancer | Metastatic Invasive Breast Cancer
NCT01091454

Completed

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

Triple-negative Breast Cancer
NCT00369655

Completed

VEGF Trap in Treating Patients With Metastatic Breast Cancer

Metastatic Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer
NCT07341503

Recruiting

The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Breast Carcinoma | Hormone Receptor-Positive Breast Carcinoma
NCT02849496

Active, not recruiting

Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma | Locally Advanced Unresectable Breast Carcinoma
NCT04316117

Active, not recruiting

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Hormone Receptor Positive Breast Carcinoma | Metastatic Breast Carcinoma
NCT01142401

Completed

Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Metastatic Breast Carcinoma
NCT04849871

Active, not recruiting

Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma (BreaStBRT)

Breast Cancer | Breast Carcinoma | Stage 0 Breast Cancer | Stage I Breast Cancer
NCT05528263

Completed

Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial) (PACT)

Breast Cancer Stage I | Breast Cancer Stage II | Acupuncture | Breast Cancer Stage III | Chemotherapy-induced Peripheral Neuropathy | Early-stage Breast Cancer
NCT06570031

Active, not recruiting

ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer

Metastatic Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor-positive Breast Cancer
NCT04120246

Suspended

Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | HER2 Positive Breast Carcinoma | Metastatic Breast Carcinoma | Refractory Breast Carcinoma
NCT04560439

Withdrawn

Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8
NCT07487519

Not yet recruiting

Phase II Study of HLX43 Monotherapy or Combined With Immune Checkpoint Inhibitors in Patients With Locally Advanced, Recurrent, or Metastatic Triple-negative Breast Cancer.

Breast Cancer (Triple Negative Breast Cancer (TNBC))
NCT07269691

Not yet recruiting

RaSOLVE: 125I Radioactive Seed Marking Effects on Pathological Complete Response Rate and Prognosis Post-Neoadjuvant Therapy in Early/Advanced Breast Cancer

Breast Cancer | Breast Cancer Early Stage Breast Cancer (Stage 1-3)
NCT07161791

Not yet recruiting

Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer

Breast Cancer | Triple Negative Breast Cancer (TNBC)
NCT07053085

Recruiting

A Study of Surgery and Radiotherapy in People With Breast Cancer

Metastatic Breast Cancer | HER2-positive Breast Cancer
NCT07019337

Not yet recruiting

Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer

Metastatic Breast Cancer | HER2-positive Breast Cancer
NCT06677879

Recruiting

A Prospective Cohort Study of Proton and Photon Therapy for Left-sided Breast Cancer.

Breast Cancer
NCT06102824

Recruiting

Organoid-based Functional Precision Therapy for Advanced Breast Cancer (ORIENTA)

Advanced Breast Cancer | HER2-negative Breast Cancer
NCT03788083

Recruiting

Intratumoral TriMix Injections in Early Breast Cancer Patients (TMBA)

Breast Cancer Female | Early-stage Breast Cancer
NCT07541703

Active, not recruiting

Independent, External, Blinded Retrospective Validation of an AI-based Prognostic Assay in ER-Positive/HER2-Negative Early Breast Cancer

Breast Cancer | Early Breast Cancer | ER-Positive HER2-Negative Breast Cancer
NCT05963997

Completed

A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer (SUMIT-ELA)

Breast Cancer | Metastatic Breast Cancer | Locally Advanced Breast Cancer
NCT04556773

Active, not recruiting

A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer (DB-08)

Metastatic Breast Cancer
NCT03571633

Active, not recruiting

Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer (BREASTIMMU02)

HER2-positive Breast Cancer | Operable Breast Cancer
NCT05954143

Terminated

Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast Cancer

Metastatic Breast Cancer | HER2-positive Breast Cancer
NCT03755141

Completed

Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer

Metastatic Breast Cancer | HER2-positive Breast Cancer
NCT02595762

Completed

A Study of Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer | Locally Advanced Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations